211 related articles for article (PubMed ID: 28476051)
1. Impaired Corneal Sensation and Nerve Loss in a Type 2 Rat Model of Chronic Diabetes Is Reversible With Combination Therapy of Menhaden Oil, α-Lipoic Acid, and Enalapril.
Davidson EP; Coppey LJ; Shevalye H; Obrosov A; Kardon RH; Yorek MA
Cornea; 2017 Jun; 36(6):725-731. PubMed ID: 28476051
[TBL] [Abstract][Full Text] [Related]
2. Effect of combination therapy consisting of enalapril, α-lipoic acid, and menhaden oil on diabetic neuropathy in a high fat/low dose streptozotocin treated rat.
Davidson EP; Holmes A; Coppey LJ; Yorek MA
Eur J Pharmacol; 2015 Oct; 765():258-67. PubMed ID: 26291662
[TBL] [Abstract][Full Text] [Related]
3. Early vs. late intervention of high fat/low dose streptozotocin treated C57Bl/6J mice with enalapril, α-lipoic acid, menhaden oil or their combination: Effect on diabetic neuropathy related endpoints.
Yorek MS; Obrosov A; Shevalye H; Coppey LJ; Kardon RH; Yorek MA
Neuropharmacology; 2017 Apr; 116():122-131. PubMed ID: 28025096
[TBL] [Abstract][Full Text] [Related]
4. Effect of inhibition of angiotensin converting enzyme and/or neutral endopeptidase on vascular and neural complications in high fat fed/low dose streptozotocin-diabetic rats.
Davidson EP; Coppey LJ; Holmes A; Yorek MA
Eur J Pharmacol; 2012 Feb; 677(1-3):180-7. PubMed ID: 22198047
[TBL] [Abstract][Full Text] [Related]
5. Effect of Dietary Content of Menhaden Oil with or without Salsalate on Neuropathic Endpoints in High-Fat-Fed/Low-Dose Streptozotocin-Treated Sprague Dawley Rats.
Davidson EP; Coppey LJ; Shevalye H; Obrosov A; Yorek MA
J Diabetes Res; 2018; 2018():2967127. PubMed ID: 30057911
[TBL] [Abstract][Full Text] [Related]
6. Effect of Early and Late Interventions with Dietary Oils on Vascular and Neural Complications in a Type 2 Diabetic Rat Model.
Coppey L; Davidson E; Shevalye H; Obrosov A; Yorek M
J Diabetes Res; 2019; 2019():5020465. PubMed ID: 31485451
[TBL] [Abstract][Full Text] [Related]
7. Effect of enriching the diet with menhaden oil or daily treatment with resolvin D1 on neuropathy in a mouse model of type 2 diabetes.
Shevalye H; Yorek MS; Coppey LJ; Holmes A; Harper MM; Kardon RH; Yorek MA
J Neurophysiol; 2015 Jul; 114(1):199-208. PubMed ID: 25925322
[TBL] [Abstract][Full Text] [Related]
8. Enriching the diet with menhaden oil improves peripheral neuropathy in streptozotocin-induced type 1 diabetic rats.
Coppey LJ; Davidson EP; Obrosov A; Yorek MA
J Neurophysiol; 2015 Feb; 113(3):701-8. PubMed ID: 25376787
[TBL] [Abstract][Full Text] [Related]
9. Rat Models of Diet-Induced Obesity and High Fat/Low Dose Streptozotocin Type 2 Diabetes: Effect of Reversal of High Fat Diet Compared to Treatment with Enalapril or Menhaden Oil on Glucose Utilization and Neuropathic Endpoints.
Holmes A; Coppey LJ; Davidson EP; Yorek MA
J Diabetes Res; 2015; 2015():307285. PubMed ID: 26229968
[TBL] [Abstract][Full Text] [Related]
10. Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic rats.
Oltman CL; Davidson EP; Coppey LJ; Kleinschmidt TL; Dake B; Yorek MA
Eur J Pharmacol; 2011 Jan; 650(2-3):556-62. PubMed ID: 21040718
[TBL] [Abstract][Full Text] [Related]
11. ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats.
Coppey LJ; Davidson EP; Rinehart TW; Gellett JS; Oltman CL; Lund DD; Yorek MA
Diabetes; 2006 Feb; 55(2):341-8. PubMed ID: 16443766
[TBL] [Abstract][Full Text] [Related]
12. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve.
Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Lund DD; Yorek MA
Diabetes; 2001 Aug; 50(8):1927-37. PubMed ID: 11473057
[TBL] [Abstract][Full Text] [Related]
13. Effect of fidarestat and alpha-lipoic acid on diabetes-induced epineurial arteriole vascular dysfunction.
Yorek MA; Coppey LJ; Gellett JS; Davidson EP; Lund DD
Exp Diabesity Res; 2004; 5(2):123-35. PubMed ID: 15203883
[TBL] [Abstract][Full Text] [Related]
14. Changes in corneal innervation and sensitivity and acetylcholine-mediated vascular relaxation of the posterior ciliary artery in a type 2 diabetic rat.
Davidson EP; Coppey LJ; Holmes A; Yorek MA
Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1182-7. PubMed ID: 22273725
[TBL] [Abstract][Full Text] [Related]
15. Early loss of innervation of cornea epithelium in streptozotocin-induced type 1 diabetic rats: improvement with ilepatril treatment.
Davidson EP; Coppey LJ; Yorek MA
Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8067-74. PubMed ID: 23169880
[TBL] [Abstract][Full Text] [Related]
16. Effect of mitoquinone (Mito-Q) on neuropathic endpoints in an obese and type 2 diabetic rat model.
Fink B; Coppey L; Davidson E; Shevalye H; Obrosov A; Chheda PR; Kerns R; Sivitz W; Yorek M
Free Radic Res; 2020 May; 54(5):311-318. PubMed ID: 32326763
[TBL] [Abstract][Full Text] [Related]
17. The effects of treatment with alpha-lipoic acid or evening primrose oil on vascular hemostatic and lipid risk factors, blood flow, and peripheral nerve conduction in the streptozotocin-diabetic rat.
Ford I; Cotter MA; Cameron NE; Greaves M
Metabolism; 2001 Aug; 50(8):868-75. PubMed ID: 11474472
[TBL] [Abstract][Full Text] [Related]
18. Nerve conduction velocity and evoked potential latencies in streptozotocin-diabetic rats: effects of treatment with an angiotensin converting enzyme inhibitor.
Manschot SM; Gispen WH; Kappelle LJ; Biessels GJ
Diabetes Metab Res Rev; 2003; 19(6):469-77. PubMed ID: 14648806
[TBL] [Abstract][Full Text] [Related]
19. Effect of treatment of high fat fed/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complications.
Davidson EP; Coppey LJ; Holmes A; Dake B; Yorek MA
Eur J Pharmacol; 2011 Oct; 668(3):497-506. PubMed ID: 21816138
[TBL] [Abstract][Full Text] [Related]
20. Differences and similarities in development of corneal nerve damage and peripheral neuropathy and in diet-induced obesity and type 2 diabetic rats.
Davidson EP; Coppey LJ; Kardon RH; Yorek MA
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1222-30. PubMed ID: 24519423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
